20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Postoperative Complications in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakelyan, K; Blum, M; Bubalo, G; Dragun, D; Falck, JR; Fechner, M; Flemming, B; Gürgen, D; Haase, M; Hentschel, J; Hoff, U; Manthati, VL; Niendorf, T; Pohlmann, A; Rothe, M; Schunck, WH; Seeliger, E; Zhu, Y | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Postoperative Complications
| Article | Year |
|---|---|
A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Kidney Injury; Animals; Cardiac Surgical Procedures; Fatty Acids; Humans; Hydroxyeicosatetraenoic Acids; Ischemia; Kidney; Male; Postoperative Complications; Rats; Rats, Inbred Lew; Reperfusion Injury; Signal Transduction | 2019 |